PATENT CLAIM ANALYSIS

Application Number: 15977238
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["514", "256000"]

Abstract:
Compounds of Formula I that inhibit the activity of the diacylglycerol acyltransferase 2 (DGAT2) and their uses in the treatment of diseases linked thereto in animals are described herein.

Claim (Index 3):
The method of  claim 1  wherein the method reduces portal hypertension, hepatic protein synthetic capability, hyperbilirubinemia, or encephalopathy.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 93.0
- Lexical Diversity: 1.18519
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15674914', '14643210', '15193440', '15693785', '14384508']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7506575530682642
- 35 USC 102 Novelty (BERT): 0.5468873680029424
- Combined Prediction Score: 0.730280534561732
- Mean Citation Score: 279.31827200000004
- Max Citation Score: 385.5273
- Similarity Product: 238.5416986759544

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test